Squamous cell carcinoma of the upper aerodigestive tract: Precursors and problematic variants

Modern Pathology

Volumn 15, Issue 3, 2002, Pages 229-254

  Wenig, Bruce M ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Genetics; Pathogenesis; Premalignant lesions; Squamous cell carcinoma; Upper aerodigestive tract

Indexed keywords

CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CARCINOGENESIS; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; EPITHELIUM; GENETICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNGECTOMY; MOLECULAR BIOLOGY; MORPHOLOGY; PATHOGENESIS; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT CANCER; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PRECANCEROUS CONDITIONS; TERMINOLOGY;

EID: 0036130026     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880520     Document Type: Review

References (126)

1. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers
2. Oral leukoplakia and malignant transformation
3. Erythroplasia: The earliest sign of asymptomatic oral cancer
4. Clinical criteria for identifying early oral and oropharyngeal carcinoma: Erythroplasia revisited
5. Quantitation of DNA ploidy in squamous intraepithelial neoplasia of the laryngeal glottis
6. Premalignant lesions of the larynx
7. Pre-invasive lesions of the upper aerodigestive tract. Histologic definitions and clinical implications
8. Laryngeal dysplasia. A clinicopathologic study
9. Conventional squamous cell carcinoma
10. Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract
11. Precursors of squamous cell carcinoma
12. The Ljubljana classification: A practical strategy for the diagnosis of laryngeal precancerous lesions
13. Laryngeal keratosis and subsequent carcinoma
14. Isolated laryngeal keratosis: Its relation to carcinoma of the larynx based on clinicopathologic study of 87 consecutive cases with long-term follow-up
15. Keratosis of the larynx
16. Hyperkeratosis of the larynx
17. The transformation of laryngeal leukoplakia to cancer
18. Diseases of the larynx, hypopharynx and esophagus
19. Laryngeal precancer: A review of the literature, commentary, and comparison with oral leukoplakia
20. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords - A follow-up study
21. Quantitation of DNA ploidy in squamous intraepithelial neoplasia of the laryngeal glottis
22. Clues to the life history of carcinoma in-situ of the larynx
23. Carcinoma in-situ and microinvasive squamous carcinoma of the laryngeal glottis
24. Carcinoma in situ and evaluation of epithelial changes in laryngopharyngeal biopsies
25. Diagnosis and grading of malignancy in 23 squamous epithelial lesions of the larynx with DNA cytomorphometry
26. Histologic changes in the larynx in relation to smoking habits
27. Distribution of basement membrane in squamous cell carcinoma of the head and neck
28. Carcinoma in situ of the larynx - Clinical appearance and treatment
29. Natural history and management of keratosis, atypia, carcinoma in situ and microinvasive cancer of the larynx
30. Premalignant laryngeal lesions - A laryngologist's viewpoint
31. Precancerous lesions of the larynx
32. Cancer of the supraglottic larynx: A review of 260 patients
33. Superficial extending carcinoma of the hypopharynx: Report of 26 cases of an underestimated carcinoma
34. "Early" cancer of the larynx: The concept as defined by clinicians, pathologists, and biologists
35. Benign squamous proliferations
36. Miscellaneous tumor-like lesions
37. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx
38. General principles of head and neck pathology
39. DNA analysis of head and neck squamous cell carcinoma by flow cytometry
40. DNA quantification and histologic characteristics of squamous cell carcinoma of the upper aerodigestive tract
41. Overexpression of p53 in head and neck cancer
42. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma
43. Squamous papillary neoplasia of the upper aerodigestive tract
44. Exophytic and papillary squmaous cell carcinoma of the larynx: A clinicopathologic series of 104 cases
45. Papillary squamous cell carcinomas of the upper aerodigestive tract: A clinicopathologic and molecular study
46. The pathology of head and neck tumors: Verrucous carcinoma, part 15
47. Ackerman's tumor (verrucous carcinoma) of the larynx. A clinicopathologic study of 77 cases
48. Verrucous-squamous carcinomas of the oral cavity. A clinicopathologic study of 104 cases
49. Verrucous carcinoma
50. Verrucous hyperplasia of the oral mucosa
51. Proliferative verrucous leukoplakia. A long-term study of thirty patients
52. Proliferative verrucous leukoplakia and verrucous hyperplasia
53. Proliferative verrucous leukoplakia and its related lesions
54. Verruca vulgaris of the larynx. A distinctive lesion of probable viral origin confused with verrucous carcinoma
55. Sarcomatoid carcinoma of the head and neck
56. Spindle-cell carcinoma of the aerodigestive tract mucosa: An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors
57. Spindle-cell carcinoma of the aerodigestive tract: An immunohistochemical analysis of 21 cases
58. Spindle cell carcinoma of the larynx: Review of 26 cases including DNA content and immunohistochemistry
59. Myogenic differentiation in spindle cell (sarcomatoid) carcinoma of the upper aerodigestive tract
60. Distinctive immunohistochemical labeling of epithelial and mesenchymal elements in laryngeal pseudosarcoma
61. Coexpression of keratin and desmin in a carcinosarcoma involving the maxillary alveolar ridge
62. Sarcomatoid carcinoma: An ultrastructural study with light microscopic and immunohistochemical correlation of 10 cases from various anatomic sites
63. Immunohistochemical p53 expression patterns in sarcomatoid carcinomas of the upper respiratory tract
64. Inflammatory myofibroblastic pseudotumors of the larynx: A clinicopathologic report of eight cases including immunohistochemical and ultrastructural analysis
65. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor. A comparative immunohistochemical study
66. TPM-ALK fusion genes and ALK expression in inflammatory myofibroblastic tumor
67. Basaloid-squamous carcinoma of the tongue, hypopharynx and larynx
68. Basaloid squamous cell carcinoma of the head and neck: A clinicopathologic and immunohistochemical study of 40 cases
69. Basaloid squamous cell carcinoma of the nasal cavity and paranasal sinuses
70. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry
71. Ultrastructural distinction of basaloid-squamous carcinoma and adenoid cystic carcinoma
72. World health organization histological classification of tumours
73. Lymphoepithelial carcinoma of the larynx, hypopharynx, and trachea
74. Lymphoepithelial carcinoma of the larynx and hypopharynx: Study of eight cases with relationship to Epstein-Barr virus (EBV) and p53gene alterations, and review of the literature
75. Epstein-Barr virus by in situ hybridization in fine-needle aspiration biopsies
76. Squamous cell carcinoma variants
77. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin
78. Incidence of multiple primary cancers. III. Cancers of the respiratory and upper digestive system as multiple primary cancers
79. Multiple primary malignant tumors of the head and neck
80. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus and lung
81. Field cancerization: Are multiple primary cancers monoclonal or polyclonal?
82. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluoresence in situ hybridization
83. Tumor cell interactions with the extracellular matrix during invasion and metastasis
84. Multiple head and neck tumors: Evidence for common clonal origin
85. Genetic progression model for head and neck cancer: Implications for field cancerization
86. Risk factors in head and neck cancer
87. Head and neck cancer
88. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in northern Italy
89. Epidemiology
90. Human papillomavirus infection in the malignant and premalignant head and neck epithelium
91. Detection of human papillomavirus-genomic DNA in oral epithelial dysplasia, oral smokeless tobacco-associated leukoplakias, and epithelial malignancies
92. Human papillomavirus and head and neck cancer: Epidemiology and molecular biology
93. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product
94. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
95. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck
96. Cellular and molecular biology of the cancer cell
97. Multiple primary malignant tumors: A survey of the literature and statistical study
98. Head and neck cancer in the young: A prognostic conundrum?
99. Head and neck cancer in nonsmokers: A distinct clinical and molecular entity
100. Genetic predisposition to cancer with special reference to mutagen sensitivity
101. Bleomycin-induced chromosome damage in lymphocytes of medullary lymphoid carcinoma patients and their family members
102. Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis
103. Chromosome sensitivity to bleomycin-induced mutagenesis as independent risk factor for aerodigestive tract cancers
104. Mutagen senstivity in upper aerodigestive tract cancer: A case-control analysis
105. Mutagen sensitivity in patients with head and neck cancer: A biologic marker for risk of multiple primary malignancies
106. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract
107. Mutagen sensitivity: A biologic marker of cancer susceptibility
108. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma
109. Allelic loss at chromosome 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer
110. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck
111. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
112. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas
113. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas
114. Frequent novel DNA copy number increase in squamous cell head and neck tumors
115. Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa
116. Genomic alterations associated with malignancy in head and neck cancer
117. Improved prognostic assessment of head-neck carcinomas by new genetic markers
118. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas
119. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas
120. Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx
121. Molecular classification of cancer: Class discovery and gene expression monitoring
122. Observing the living genome
123. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
124. Systematic variation in gene expression patterns in human cancer cell lines
125. Molecular classification of head and neck squamous cell carcinoma using CDNA microassays